| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
1.41 0 (0%) |
11-19 16:00 |
|
Open: |
1.41 |
Pre close: |
1.41 |
Target:
|
2.55
|
|
High: |
1.46 |
Low: |
1.34 |
Resistance:
|
2.18
2.75
|
|
Volume: |
2,514,731 |
Market Cap: |
80M |
Support:
|
1.26
1.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.40
 |
MACD |
MACD(12,26):
|
-0.25  |
|
MA(20): |
2.00 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
2.12 |
Stochastic Oscillator |
%K(14,3):
|
12.37 |
|
MA(250): |
2.08 |
%D(3): |
11.20 |
|
Average Volume(K) |
3-Month: |
60416
|
52-Week |
High:
|
2.92 |
|
10-Days: |
139369 |
Low: |
1.26 |
|
RSI |
RSI(14):
|
32.02 |
Change(%): |
-28.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.210 |
Return on Equity (ttm) |
-18.3 |
Shares Out. (M) |
56.87 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-15.9 |
Shares Float (M) |
54.05 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.07 |
% Held by Insiders |
5.00 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
266.7 |
% Held by Institutions |
38.10 |
|
Forward EPS |
-0.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.380 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.71 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.02 |
|
Profit Margin |
-46.95 |
Operating Cash Flow
(M) |
-19.86 |
P/S |
195577312.00 |
|
Operating Margin |
-52.24 |
Levered Free Cash Flow
(M) |
-16.30 |
P/CF |
-4.04 |
|
|
|
|
|
|
